Detection and clinical relevance of early disseminated breast cancer cells depend on their cytokeratin expression pattern
- PMID: 20449649
- DOI: 10.1007/s10549-010-0911-2
Detection and clinical relevance of early disseminated breast cancer cells depend on their cytokeratin expression pattern
Abstract
The factors determining the clinical relevance of disseminated tumor cells (DTC) in breast cancer patients are largely unknown. Here we compared the specificity and clinical performance of two antibodies frequently used for DTC detection. Reactivities of antibodies A45-B/B3 (A45) and AE1/AE3 (AE) for selected cytokeratins (CK) were assessed by 2-DE Western Blot analysis. Using these antibodies bone marrow aspirates from 391 breast cancer patients (M(0), pT1-3, pN0-3) were screened for the presence of DTC. To obtain prognostic information, patients were followed up over a median of 83 months for time to relapse and 99 months for time to death. Among the analyzed CK, AE detected CK5, CK7, CK8, and CK19, whereas A45 recognized CK7 and CK18. In total, 24 of 391 patients (6.1%) were DTC-positive for A45, and 41 (10.5%) for AE. Although concordance between the two antibodies was 84.4%, overlap among positive cases was only 3.2%. DTC-positivity with AE and A45 was more frequent in patients of higher nodal status (P=0.019 and P=0.036, respectively). Nearly all patients with A45-positive DTC had hormone receptor-positive tumors (23/24), while detection of AE-positive DTC was more frequent among hormone receptor negative patients (P=0.006). Survival analyses of all patients revealed shorter distant disease-free survival (P=0.039) for patients with A45-positive DTC, whereas the prognostic relevance of AE-positive DTC was restricted to node-positive patients. The clinical utility of immunocytochemical (ICC) DTC detection depends on the anti-CK antibody used, which may reflect the complex CK composition of DTC.
Similar articles
-
Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse.Clin Cancer Res. 2008 Jun 1;14(11):3306-11. doi: 10.1158/1078-0432.CCR-07-4749. Clin Cancer Res. 2008. PMID: 18519757
-
Prognostic impact of Thomsen-Friedenreich tumor antigen and disseminated tumor cells in the bone marrow of breast cancer patients.Breast Cancer Res Treat. 2007 Jan;101(1):17-25. doi: 10.1007/s10549-006-9271-3. Epub 2006 Jun 29. Breast Cancer Res Treat. 2007. PMID: 16807671
-
Prognostic significance of disseminated tumor cells as detected by quantitative real-time reverse-transcriptase polymerase chain reaction in patients with breast cancer.Clin Breast Cancer. 2006 Jun;7(2):146-52. doi: 10.3816/CBC.2006.n.024. Clin Breast Cancer. 2006. PMID: 16800974 Clinical Trial.
-
Clinical relevance of occult metastatic cells in the bone marrow of patients with different stages of breast cancer.Clin Breast Cancer. 2000 Oct;1(3):217-25. doi: 10.3816/CBC.2000.n.018. Clin Breast Cancer. 2000. PMID: 11899646 Review.
-
Disseminated tumor cells in breast cancer: detection, characterization and clinical relevance.Future Oncol. 2006 Aug;2(4):553-61. doi: 10.2217/14796694.2.4.553. Future Oncol. 2006. PMID: 16922621 Review.
Cited by
-
Clinical relevance and biology of circulating tumor cells.Breast Cancer Res. 2011;13(6):228. doi: 10.1186/bcr2940. Epub 2011 Nov 1. Breast Cancer Res. 2011. PMID: 22114869 Free PMC article. Review.
-
In vitro validation of an ultra-sensitive scanning fluorescence microscope for analysis of circulating tumor cells.APMIS. 2014 Jun;122(6):545-51. doi: 10.1111/apm.12183. Epub 2013 Oct 29. APMIS. 2014. PMID: 24164622 Free PMC article.
-
Epithelial-mesenchymal plasticity is a decisive feature for the metastatic outgrowth of disseminated WAP-T mouse mammary carcinoma cells.BMC Cancer. 2015 Mar 26;15:178. doi: 10.1186/s12885-015-1165-5. BMC Cancer. 2015. PMID: 25886487 Free PMC article.
-
Prognostic value of disseminated tumor cells in unresectable pancreatic ductal adenocarcinoma: a prospective observational study.BMC Cancer. 2022 Jun 3;22(1):609. doi: 10.1186/s12885-022-09714-x. BMC Cancer. 2022. PMID: 35659265 Free PMC article.
-
In Vitro Modeling of Reoxygenation Effects on mRNA and Protein Levels in Hypoxic Tumor Cells upon Entry into the Bloodstream.Cells. 2020 May 25;9(5):1316. doi: 10.3390/cells9051316. Cells. 2020. PMID: 32466213 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous